Whilst the diagnosis of CF can often be challenging, improvements in diagnostics, including CFTR gene sequencing methodologies [32], should aid with earlier detection and thereby earlier implementation of directed therapies, albeit with the caveat that ongoing work around new therapeutic options for this group of pwCF should remain a research priority. The gene discussed is CFTR; the disease is cystic fibrosis.